secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2026-08-12T21:07:15+00:00
Accession:  0001522767-26-000164
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q2 2026 revenue up 6% to $41.9M; net loss widens to $3.6M
-----------------------------------------------------------------

- Revenue of $41.9M in Q2 2026, up 6% from $39.5M in Q2 2025; H1 revenue $81.4M vs $77.4M.
- GAAP net loss widened to $3.6M in Q2 vs $1.4M a year ago; non-GAAP net loss $2.4M vs $0.3M profit.
- Non-GAAP adjusted EBITDA fell to $3.9M (9% margin) from $4.8M (12% margin) in Q2 2025.
- GAAP gross margin 39% vs 40%; non-GAAP gross margin 40% vs 42%, down YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/0001522767-26-000164-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/mrmd-20260812.htm
  HTML page:      https://secwatch.observer/filing/0001522767-26-000164

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer